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Abstract
Purpose of Review Over the past two decades, advances have been made in understanding the pathophysiology of cancer-
associated weight loss, termed “cachexia.” To date, there is no proven effective intervention to completely reverse cachexia
and there are no approved drug therapies to treat it. This paper will review relevant literature in relation to communicating with
adolescents and young adults about cancer-associated weight loss.
Recent Findings Adolescents and young adults (AYAs) who have cancer are a unique group of patients due to their stage of
development and maturity.
Summary This article outlines issues specific to this patient cohort that need to be considered to better understand the impact of
cachexia and explore pertinent matters when communicating with AYAs in relation to cachexia.
Keywords Adolescents and young adults . Cancer-associated weight loss . Cachexia
Introduction
Cancer-associated weight loss or cachexia is a “multifactorial
syndrome characterized by an ongoing loss of skeletal muscle
mass, with or without loss of fat mass that cannot be fully
reversed by conventional nutritional support and leads to pro-
gressive functional impairment” ( [1], p.489). The pathophys-
iology of cancer cachexia is multifarious and reflective of this
a multimodal approach to its management has been advocated
[2]. However, to date, a successful treatment regime has not
been definitely tested and there is a dearth of local practice
guidelines and approved treatments for cancer cachexia.
Previous research has uncovered the holistic impact of cancer
cachexia for both patients and their carers; however, the vast
majority of this work has been conducted with adult cancer
patients. For adolescents and young adults (AYAs), the impact
of cancer cachexia is likely to be distinct from older age
groups given the challenges of this development stage. How
we communicate with this group in relation to cachexia is
particularly relevant as AYAs are regarded as particularly vul-
nerable [3]. Adolescence and early adulthood is known to be a
distinct and complex development stage in a person’s life not
only because of cognitive, emotional, and physical changes
but also because of psychosocial challenges related to self-
identity, relationships with family and peers, development of
autonomy, sexuality, and education/work-related issues [4].
Defining Adolescents and Young Adults
The term “adolescents and young adults” has been variously
described in the literature with differing age ranges. For ex-
ample, previous cancer research has operationally defined
AYAs as follows: 10–19 [5] 10–26 [6]; 11–21 [7]; 11–24
[8]; 13–21 [9]; 13 plus [10]; 14–39 [11, 12]; 15–25 [13, 14];
15–29 [15]; 15–30 [16]; 15–34 [17]; 15–39 [18–25]; 15–29
[26]; 16–29 [27, 28]; 16–30 [29, 30]; 18–25 [31]; 18–35 [32];
18–39 [33]; 18–40 [34]; 18–44 [35]; 18–45 [36].
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No formal unified agreement of the age rage for AYAs
exists within the literature reviewed. As a result, the
aforementioned age ranges are used interchangeably and
this makes comparisons across research studies all the
more complex. However, what is clear is that this stage
of life marks key transition years from adolescent to
adulthood and for most persons are the most dynamic
and confounding years of life [4]. It is recognized that
AYAs with cancer are a unique cohort due to their distinct
biology, maturing hormonal and personal development,
transitions in autonomy, demands in education and the
workplace, and their place within the family/family re-
sponsibilities [37].
Cancer Incidence and Research in Adolescents
and Young Adults
Globally, cancer remains a major cause of both morbidity
and mortality across all age groups. Given there are more
than one million new diagnoses of cancer worldwide in
AYAs per annum [38], the global burden is greater than in
all other age groups. Cancer is generally a disease asso-
ciated with increasing age and thus the majority of re-
search has focused on such populations. As such, research
into the impact of cancers that occur at the juncture be-
tween pediatric and adult oncology remains in its infancy
[39]. It is widely accepted that AYAs with cancer should
have age-appropriate care to meet their needs and such
care should be evidence based [40]. However, research
involving AYAs is seldom the focus of cancer studies
and this population is known to be under-researched [37,
41]. This is in stark contrast to the fact that the number of
life-years affected by cancer is greater for AYAs than in
any other age group [42]. It is also worth noting that
internationally, recruitment of AYAs above the age of 15
into cancer trials is poor. Most notable, this is seen to
directly relate with deficits in survival gains for patients
aged 15–39 years [43]. Thus, while acknowledging the
needs for additional research with this cohort, any such
research needs to focus on innovative ways of engaging
AYAs by better understanding the barriers and facilitators
to recruitment and retention to maximize scientific ad-
vances and understanding of cancer-associated weight
loss in this population.
Cancer-Associated Weight Loss
Patients with cancer are known to experience weight loss
for a variety of reasons including, stress/anxiety, poor
symptom management, and treatment-related factors.
However, cancer-associated weight loss or cachexia is
multifactorial syndrome characterized by progressive and
involuntary weight loss and loss of muscle mass. There
are three main factors that influence this syndrome: met-
abolic dysregulation, creating a negative energy balance;
catabolism; and neuro-hormonal dysregulation. It is be-
yond the scope of this review to discuss these in-depth,
but previous literature has detailed the pathophysiology of
cancer cachexia [1, 44]. As outlined by Fearon et al. [1],
cancer cachexia is a continuum which has three key
stages, namely precachexia, cachexia, and refractory ca-
chexia (Fig. 1).
The hallmark of weight loss associated with cancer ca-
chexia is that there is a preferential loss of lean muscle
mass and that the weight loss cannot be reversed with con-
ventional feeding alone [43]. Thus, and in accordance with
the consensus definition of cancer cachexia [1], merely
assessing weight loss does not reflect the multidimensional
syndrome of cancer cachexia. Furthermore, BMI has pre-
viously been used to assess for cachexia if weight loss is
not known [45]. However, caution should be exercised in
relation to this given the rise in prevalence of overweight
Fig. 1 Stages of cachexia. Reprinted from The Lancet Oncology, Volume 12, Fearon K, et al., “Definition and classification of cancer cachexia: an
international consensus,” pages 489–95, ©2011, with permission from Elsevier
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and obese adults and children, which rose by 27.5% and
47.1% respectively between 1980 and 2013 [46].
Research focusing on gaining insight and understand-
ing into the metabolic anomalies associated with cancer
cachexia has proliferated in the last two decades. In par-
allel to this, clinical research efforts have focused on the
potential management of cachexia aimed at reversing or
ameliorating the associated weight loss. Most recently, the
international Pre-MENAC and MENAC trials [43, 47],
using a multimodal approach to cancer cachexia manage-
ment, are reflective of the multifactorial syndrome itself
[48]. However, preventative and therapeutic treatment op-
tions thus far have been shown to be largely ineffective
and currently there is no notable pharmacological agent
that successfully halts and reverses the weight loss asso-
ciated with cancer cachexia. Furthermore, the optimal
treatment for cachexia in patients with cancer has yet to
be determined and currently there is no licensed treatment
for cancer cachexia [43]. In practice today, despite much
time and investment into clinical research, standardized
local guidelines for the assessment, classification, and
treatment of cachexia have still not been developed [49].
This only serves to compound the relevance of cachexia
in negatively affecting both morbidity and mortality.
Globally, cachexia is directly responsible for 20% of all
cancer deaths, equating to more than 7.4 million deaths
worldwide annually [50, 51].
Cancer-Associated Weight Loss: Impact
on Patients and Their Families
Cancer cachexia is associated with reduced functionality
and adversely impacts on activities of daily living [52],
unfavorable psychosocial impact [53], reduced tolerance
to anticancer therapy [54], and reduced survival [55].
Furthermore, it impacts not only patients but also their
family members [56]. In particular, the lack of under-
standing about the role of food in cancer cachexia man-
agement can lead to family conflicts and deleteriously
affect family dynamics [57]. To date, the research which
has explored the lived experience and impact of cachexia
has focused on adult patients. While previous cancer stud-
ies with AYAs have highlighted cancer cachexia in rela-
tion to symptoms experienced [4, 58], no study has ex-
plored the impact of this syndrome in-depth with AYAs.
Due to the developmental stage of AYAs, the holistic im-
plications are likely to be far reaching and distinctive
from adult patients. Most notably, the psychosocial chal-
lenges of this stage of maturity [4] coupled with the
biopsychosocial ramifications of cancer cachexia [57] will
make the impact unique from older age groups most com-
monly studied.
In relation to nutritional problems in cancer, previous
descriptive research conducted with children and their
parents (n = 69) has highlighted that parents as well as
children need comprehensive and regular information
[59]. Indeed, information on both diet and nutrition have
been reported as an unmet among AYA patients with can-
cer [12]. This is reflective of work that has previously
been conducted with an adult cancer cachexia population,
where the patient and also the patient’s family needs sup-
port to cope with and provide care with nutritional issues
[60]. The role of family may be all the more important for
AYAs, as they may still be dependent on their families for
food purchase and preparation and may experience “pres-
sure to eat” from both family at home and through peer
pressure from their social circle [61].
Previous research conducted in relation to communica-
tion about weight with adolescents outlines the sensitivities
that need to be considered when engaging in communica-
tion about weight with this cohort. In particular, the need to
avoid communication which induces negative emotional
reactions is outlined [62]. This is a key message as previ-
ous research conducted with an adult cachectic population
outlined negative labelling that family used and which in-
advertently caused hurt or sadness such as “the look of
someone from Belsen” [63]. Such terminology may be
particularly damaging for AYAs with cachexia, particular-
ity in relation to self-image and sexuality due to their stage
of maturity. Thus, when providing additional information
in relation to cancer cachexia to AYAs, both health care
professionals and parents should be educated to identify
and desist from using such negative terminology and assist
in promoting a supportive dialogue in relation to the role of
food and cancer-associated weight loss.
One of the defining characteristics of cachexia is
weight loss that manifests as preferential loss of lean mus-
cle mass, which is obvious visually. Given that AYAs are
particularly concerned with how others see them and they
often do not want to be seen as someone who is “sick,”
addressing the visuality of cachexia is a key area of con-
cern for future care consideration to support AYAs adjust-
ment of body changes. The mode of delivery of such
future care also needs to be addressed as many AYAs turn
to the internet for both information and for support from
peers [64]. Providing age-appropriate information and a
forum for discussion in relation to cachexia is a necessity
alongside age-appropriate person-centered health care
[65] ensuring the values, goals, and preferences unique
to this population are understood.
Cancer-associated weight loss is known to resonate
with patients and family members and indeed health care
professionals in terms of mortality [57, 66]. Progressive
cachexia is indicative of a poorer prognosis and shorter
survival time [67]. Within an adult cancer population,
Curr Oncol Rep           (2019) 21:15 Page 3 of 6    15 
addressing cachexia may be avoided by health care pro-
fessionals due to concern of it leading into an end of life
conversation [68]. In relation to AYAs (with and without
chronic illness), research has demonstrated that they are
willing to discuss end of life decision-making so it is vital
that it is addressed in clinical practice to provide quality
end of life care [69]. The timeliness of such conversation
is particularly relevant as previous AYAs with advanced
cancer outlined that discussions about end of life were
close to death and this negatively impacted on their ability
to psychologically prepare for death [70]. Advance care
planning is an essential part of care and this should en-
compass cachexia and its management, if this is relevant.
The uniqueness of the AYAs population pertains to this
aspect of care and end of life care preferences as these
patients may differ from those of the adult population.
Additional research is warranted to explore this further
and develop age relevant resources to assist this process.
Conclusion and Future Research Direction
There is a current dearth of information in relation to
cancer-associated weight loss and AYAs. While previous
work has been conducted in relation to cancer-associated
weight loss in an adult population, this may not highlight
the nuances in the AYAs population. Reflective of this,
the management strategies’ needs for AYAs with cancer-
associated weight loss are likely to be very different
from an adult population. To help empower and optimize
quality of life for AYAs with cancer-associated weight
loss, person-centered care which recognizes and responds
to the needs of AYAs with cancer-associated weight loss
needs to be developed. Such care must be evidence
based. To achieve this, it is essential to determine
AYAs experience of cancer-associated weight loss and
in particular, the role of their family and peers coupled
with their age-related development (including bio-
psycho-social-sexual domains) are key areas that require
additional research. In planning future work in this area,
a consensus definition of AYAs is needed to allow com-
parison across work and prevent unnecessary duplication
of efforts. Given the social impact already known in
relation to cancer cachexia and its impact on family dy-
namics (58; 54) and the psychosocial developmental
stage that AYAs are at, it would be prudent to assess
social functioning, family dynamics in AYAs with
cancer-associated weight loss.
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